ResMed: revenue, profit and dividends

In fiscal 2026, ResMed had revenue of $5.65B, up 11.9% a year on average since 2016, and net income of $1.52B (26.9% of revenue). Its dividend per share has gone up 5 years in a row, to $2.40.

Revenue, fiscal 2026

$5.65B+11.9% a year

average annual revenue growth since 2016 · +9.9% vs 2025

Net income, 2026

$1.52B

26.9% of revenue

Diluted EPS, 2026

$10.43

15.4% a year since 2016

Dividend per share, 2026

$2.40

raised 5 years in a row

Revenue growth, 5 years

12.1% a year

since 2021

Shares, 2026

146M

+3.1% since 2016

Free cash flow, 2026

$1.65B

$1.81B from operations − $156M capex

Ticker: RMD · NYSE, OTC
Sector: Health Care
Sub-industry: Health Care Equipment
Headquarters: San Diego, California
Founded: 1989
In the S&P 500 since: July 26, 2017
Latest fiscal year: 2026, ended June 30, 2026
SEC filer: Resmed Inc · CIK 0000943819

Revenue and net income

Revenue went from $921M in 2009 to $5.65B in 2026.

RevenueNet income

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Diluted earnings per share

Diluted EPS went from $0.95 in 2009 to $10.43 in 2026. Ten-year growth: 15.4% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Dividends per share

Raised 5 years in a row, every year from 2022 to 2026. Ten-year growth: 7.2% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Shares outstanding

3.1% more shares in 2026 than in 2016 (142M → 146M): new shares outweighed buybacks.

Fiscal years · diluted weighted-average shares, adjusted for splitsSource: SEC EDGAR (company filings)

Operating cash flow, capex and free cash flow

Free cash flow (operating cash flow minus capital expenditure) was $1.65B in 2026, 29.2% of revenue.

Operating cash flowCapital expenditureFree cash flow

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Year by year

Fiscal year	Revenue	Net income	Net margin	Diluted EPS	Dividend	Shares	Operating cash flow	Capex	Free cash flow
2026	$5.65B	$1.52B	26.9%	$10.43	$2.40	146M	$1.81B	$156M	$1.65B
2025	$5.15B	$1.4B	27.2%	$9.51	$2.12	147M	$1.75B	$89.9M	$1.66B
2024	$4.69B	$1.02B	21.8%	$6.92	$1.92	148M	$1.4B	$99.5M	$1.3B
2023	$4.22B	$898M	21.3%	$6.09	$1.76	147M	$693M	$120M	$574M
2022	$3.58B	$779M	21.8%	$5.30	$1.68	147M	$351M	$135M	$216M
2021	$3.2B	$475M	14.8%	$3.24	$1.56	146M	$737M	$103M	$634M
2020	$2.96B	$622M	21.0%	$4.27	$1.56	146M	$802M	$95.3M	$707M
2019	$2.61B	$405M	15.5%	$2.80	$1.48	144M	$459M	$68.7M	$390M
2018	$2.34B	$316M	13.5%	$2.19	$1.40	144M	$505M	$62.6M	$442M
2017	$2.07B	$342M	16.6%	$2.40	$1.32	142M	$414M	$62.2M	$352M
2016	$1.84B	$352M	19.2%	$2.49	$1.20	142M	$548M	$58.5M	$489M
2015	$1.68B	$353M	21.0%	$2.47	$1.12	143M	$383M	$62.5M	$321M
2014	$1.55B	$345M	22.2%	$2.39	$1.00	144M	$391M	$72.7M	$319M
2013	$1.51B	$307M	20.3%	$2.10	$0.68	146M	$403M	$63.6M	$339M
2012	$1.37B	$255M	18.6%	$1.71	—	149M	$383M	$47.1M	$336M
2011	$1.24B	$227M	18.3%	$1.44	—	157M	$283M	$66.6M	$217M
2010	$1.09B	$190M	17.4%	$1.23	—	155M	$188M	$56.9M	$131M
2009	$921M	$146M	15.9%	$0.95	—	154M	$239M	$110M	$129M